Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: Evidence for interaction?

Heart

Volumn 98, Issue 6, 2012, Pages 474-479

  Baardman, Maria E ^a   Kerstjens Frederikse, Wilhelmina S ^a   Corpeleijn, Eva ^a   De Walle, Hermien E K ^a   Hofstra, Robert M W ^a   Berger, Rolf M F ^b   Bakker, Marian K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CASE CONTROL STUDY; CHILD; CHROMOSOME ABERRATION; CONGENITAL HEART DISEASE; CONOTRUNCAL DEFECT; CONTROLLED STUDY; FEMALE; FETUS; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; NETHERLANDS; PRIORITY JOURNAL; PROGENY; REGISTER; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HEART; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84857449752     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300822     Document Type: Article

References (35)

1. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008;153:807-13.
2. Botto LD, Correa A. Decreasing the burden of congenital heart anomalies: an epidemiological evaluation of risk factors and survival. Pediatr Cardiol 2003;2003:111-21.
3. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007;115:2995-3014. (Pubitemid 46912106)
4. van Beynum IM, Kapusta L, Bakker MK, et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 2010;31:464-71.
5. Cedergren MI, Kallen BA. Maternal obesity and infant heart defects. Obes Res 2003;11:1065-71. (Pubitemid 41151583)
6. Gilboa SM, Correa A, Botto LD, et al. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2010;202:51.e1-10.
7. Mills JL, Troendle J, Conley MR, et al. Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr 2010;91:1543-9.
8. Watkins ML, Botto LD. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology 2001;12:439-46. (Pubitemid 32566486)
9. Troe EJ, Raat H, Jaddoe VW, et al. Smoking during pregnancy in ethnic populations: the Generation R study. Nicotine Tob Res 2008;10:1373-84.
10. Statistics Netherlands. http://www.cbs.nl (accessed Jul 2011).
11. Akbartabartoori M, Lean ME, Hankey CR. Smoking combined with overweight or obesity markedly elevates cardiovascular factors. Eur J Cardiovasc Prev Rehabil 2006;13:938-46. (Pubitemid 44901156)
12. McGill HC Jr, McMahan CA, Malcom GT, et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 1997;17:95-106. (Pubitemid 27057330)
13. Bruneau BG. The developmental genetics of congenital heart disease. Nature 2008;451:943-8. (Pubitemid 351301750)
14. Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007;79:714-27. (Pubitemid 47584196)
15. Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010;362:2185-93.
16. World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity. Publication No. WHO/NUT/NCD/98.1. Geneva: World Health Organization, 1997.
17. Cortina-Borja M, Smith AD, Combarros O, et al. The synergy factor: a statistic to measure interactions in complex diseases. BMC Res Notes 2009;2:105.
18. Skrondal A. Interaction as departure from additivity in case control studies: a cautionary note. Am J Epidemiol 2003;158:251-8. (Pubitemid 36944418)
19. Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-9. (Pubitemid 41126030)
20. Van derWeele TJ, Robins TM. The identification of synergism in the sufficient-component-cause framework. Epidemiology 2007;18:329-39. (Pubitemid 46624942)
21. Knol MJ, Van der Weele TJ, Groenwold RH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011;73:1873-95.
22. Kline J, Stein ZA, Susser M. Smoking: a risk factor for spontaneous abortion. N Engl J Med 1977;297:793-6. (Pubitemid 8194799)
23. Källén K. Maternal smoking and congenital heart defects. Eur J Epidemiol 1999;15:731-7. (Pubitemid 29493113)
24. Malik S, Cleves MA, Honein MA, et al. Maternal smoking and congenital heart defects: National Birth Defects Prevention Study. Pediatrics 2008;121:e810-16.
25. Hobbs CA, Cleves MA, Karim MA, et al. Maternal folate-related gene-environment interactions and congenital heart defects. Am J Obstet Gynaecol 2010;116:316-22.
26. van Beynum IM, den Heijer M, Blom HJ, et al. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 2007;100:743-53.
27. Hobbs CA, Cleves MA, Zhao W, et al. Congenital heart defects and maternal biomarkers of oxidative stress. Am J Clin Nutr 2005;82:598-604.
28. Roest PA, van Iperen L, Vis S, et al. Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteïne. Birth Defects Res A Clin Mol Teratol 2007;79:231-5. (Pubitemid 46411282)
29. Ornoy A, Rand SB, Bischitz N. Hyperglycemia and hypoxia are interrelated in their teratogenic mechanism: studies on cultured rat embryos. Birth Defects Res B Dev Reprod Toxicol 2010;89:106-15.
30. Rogers JM. Tabacco and pregnancy. Reprod Toxicol 2009;28:152-60.
31. Cooper MK, Wassif CA, Krakowiak PA, et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 2003;33:508-13. (Pubitemid 36390014)
32. Burke KT, Colvin PL, Myatt L, et al. Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster. J Lipid Res 2009;50:1146-55.
33. Lin AE, Ardinger HH, Ardinger RH Jr, et al. Cardiovascular malformations in Smith-Lemli-Opitz syndrome. Am J Med Genet 1997;68:270-8. (Pubitemid 27081807)
34. Goddeeris MM, Schwartz R, Klingensmith J, et al. Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. Development 2007;134:1593-604. (Pubitemid 46746311)
35. Goddeeris MM, Rho S, Petiet A, et al. Intracardiac septation requires hedgehog-dependent cellular contributions from outside the heart. Development 2008;135:1887-95.